Literature DB >> 24620838

Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma.

B Khodayari1, A L Michaud, S Stanic, O H Wooten, A Dublin, J A Purdy, A M Chen.   

Abstract

OBJECTIVE: To evaluate the dose received by the hippocampus among patients undergoing intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer.
METHODS: 10 patients with biopsy-proven, locally advanced nasopharyngeal cancer constituted the study population. The total prescribed dose to the planning target volume (PTV) was 70 Gy (D95%) delivered in 2.12-Gy daily fractions using IMRT. Using established anatomical guidelines, MRI co-registration and the assistance of a board-certified neuroradiologist, the right and left hippocampi were delineated on axial imaging from the CT scan obtained at simulation for each patient beginning at the most anterior portion of the lateral ventricle. IMRT treatment plans were generated without dose-volume constraints to the hippocampus. A range of dose-volume statistics was calculated.
RESULTS: The mean hippocampus volume was 6.01 ± 2.61 cm(3). The mean V20 was 72.2%; V40 was 22.0%; V50 was 10.2%; and V60 was 5.5%. The average mean, minimum and maximum hippocampus doses were 30.27 Gy (range, 19.08-47.99 Gy); 17.54 Gy (range, 11.66-33.17 Gy); and 54.95 Gy (range, 35.59-75.57 Gy), respectively. The hippocampus received a maximum dose exceeding 70 Gy in 30% of cases.
CONCLUSION: Our dosimetric analysis suggests that, for patients undergoing IMRT for nasopharyngeal cancer, the hippocampus routinely receives significantly high doses. ADVANCES IN KNOWLEDGE: The hippocampus receives a fair amount of incidental radiation during treatment for nasopharyngeal cancer. Given the importance of this structure with respect to memory and neurocognitive function, consideration should be given to identifying the hippocampus as a critical organ at risk in the IMRT optimization process.

Entities:  

Mesh:

Year:  2014        PMID: 24620838      PMCID: PMC4075526          DOI: 10.1259/bjr.20130474

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  19 in total

1.  Irradiation induces neural precursor-cell dysfunction.

Authors:  Michelle L Monje; Shinichiro Mizumatsu; John R Fike; Theo D Palmer
Journal:  Nat Med       Date:  2002-08-05       Impact factor: 53.440

2.  Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.

Authors:  A W Lee; W Foo; R Chappell; J F Fowler; W M Sze; Y F Poon; S C Law; S H Ng; S K O; S Y Tung; W H Lau; J H Ho
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

3.  Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma.

Authors:  P W Lee; B K Hung; E K Woo; P T Tai; D T Choi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

4.  Selective vulnerability to radiation in the hippocampal dentate granule cells.

Authors:  R Nagai; S Tsunoda; Y Hori; H Asada
Journal:  Surg Neurol       Date:  2000-05

5.  Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis.

Authors:  M Cheung; A S Chan; S C Law; J H Chan; V K Tse
Journal:  Arch Neurol       Date:  2000-09

6.  Neurogenesis in the adult human hippocampus.

Authors:  P S Eriksson; E Perfilieva; T Björk-Eriksson; A M Alborn; C Nordborg; D A Peterson; F H Gage
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

7.  Progress of memory function after radiation therapy in patients with nasopharyngeal carcinoma.

Authors:  Linda C W Lam; S F Leung; Y L Chan
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

8.  Asymptomatic temporal lobe injury after radiotherapy for nasopharyngeal carcinoma: incidence and determinants.

Authors:  S F Leung; L Kreel; S Y Tsao
Journal:  Br J Radiol       Date:  1992-08       Impact factor: 3.039

9.  Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis.

Authors:  Jacob Raber; Radoslaw Rola; Anthony LeFevour; Duncan Morhardt; Justine Curley; Shinichiro Mizumatsu; Scott R VandenBerg; John R Fike
Journal:  Radiat Res       Date:  2004-07       Impact factor: 2.841

10.  Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.

Authors:  Sheng-Fa Su; Shao-Ming Huang; Fei Han; Ying Huang; Chun-Yan Chen; Wei-Wei Xiao; Xue-Ming Sun; Tai-Xiang Lu
Journal:  Radiat Oncol       Date:  2013-01-22       Impact factor: 3.481

View more
  7 in total

1.  Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.

Authors:  Ping-Fang Tsai; Chi-Cheng Yang; Chi-Cheng Chuang; Ting-Yi Huang; Yi-Ming Wu; Ping-Ching Pai; Chen-Kan Tseng; Tung-Ho Wu; Yi-Liang Shen; Shinn-Yn Lin
Journal:  Radiat Oncol       Date:  2015-12-10       Impact factor: 3.481

2.  The Hippocampus Sparing Volume Modulated Arc Therapy does not Influence Plan Quality on Locally Advanced Nasopharyngeal Carcinoma Patients.

Authors:  Wendong Gu; Qilin Li; Dan Xi; Ye Tian; Juncong Mo; Honglei Pei
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

3.  Prognosis of Hippocampal Function after Sub-lethal Irradiation Brain Injury in Patients with Nasopharyngeal Carcinoma.

Authors:  Sharon Chia-Ju Chen; Yoshifumi Abe; Pen-Tzu Fang; Ya-Ju Hsieh; Yung-I Yang; Tzu-Ying Lu; Shoji Oda; Hiroshi Mitani; Shi-Long Lian; Yu-Chang Tyan; Chih-Jen Huang; Tatsuhiro Hisatsune
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

4.  The Learning Curve and Inter-Observer Variability in Contouring the Hippocampus under the Hippocampal Sparing Guidelines of Radiation Therapy Oncology Group 0933.

Authors:  Monika Konopka-Filippow; Ewa Sierko; Dominika Hempel; Rafał Maksim; Natalia Samołyk-Kogaczewska; Tomasz Filipowski; Ewa Rożkowska; Stefan Jelski; Beata Kasprowicz; Eryka Karbowska; Krzysztof Szymański; Kamil Szczecina
Journal:  Curr Oncol       Date:  2022-04-08       Impact factor: 3.109

5.  Hippocampus sparing volumetric modulated arc therapy in patients with loco-regionally advanced oropharyngeal cancer.

Authors:  Seung Won Seol; Brian H Lee; Timothy L Sita; Jay Ram Devineni; Tim J Kruser; Sean Sachdev; Michelle Gentile; Irene Helenowski; Bharat B Mittal
Journal:  Phys Imaging Radiat Oncol       Date:  2022-09-24

6.  Radiation-induced gray matter atrophy in patients with nasopharyngeal carcinoma after intensity modulated radiotherapy: a MRI magnetic resonance imaging voxel-based morphometry study.

Authors:  Lei Shi; Feng-Lei Du; Zong-Wen Sun; Lan Zhang; Yuan-Yuan Chen; Tie-Ming Xie; Pei-Jing Li; Shuang Huang; Bai-Qiang Dong; Min-Ming Zhang
Journal:  Quant Imaging Med Surg       Date:  2018-10

7.  Results of the radiation dose of head, body and tail of hippocampus in nasopharyngeal carcinoma patients treated with intensity modulated radiotherapy.

Authors:  Sun Zong-Wen; Shi Lei; Li Qinglin; Kong Yue; Du Feng-Lei; Xie Tie-Ming; Hua Yong-Hong; Hu Qiao-Ying; Chen Xiao-Zhong; Chen Yuan-Yuan; Chen Ming
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.